NVST Stock Chart & Stats
$371.00
$0.00(0.00%)
At close: 4:00 PM EDT
$371.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$351.13 - $400.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$75.62B
Enterprise Value$4.80K
Total Cash (Recent Filing)$1.08B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)64.2
Beta-0.06
Next Earnings
Aug 05, 2026EPS Estimate
5.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.42
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$523.30Price Target Upside41.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)24.97
Revenue Forecast (FY)$49.88B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthRobust free cash flow generation is a durable strength: $220M TTM and high conversion mean internal funding for capex, tuck‑in M&A and buybacks without heavy reliance on external financing. Over the next 2–6 months this underpins capital allocation and cushions cyclicality in procedure volumes.
High And Expanding Gross MarginsSustained ~55% gross margins reflect a favorable product mix (consumables, implant systems, digital offerings) and pricing power. Recent margin expansion shows operating leverage working through the business, supporting durable profitability improvement even if top‑line growth moderates over the medium term.
Product Innovation And Accretive M&AA diversified portfolio with notable new-product rollouts and targeted tuck‑ins enhances competitive positioning and recurring revenue streams. Competitive conversions and AI-enabled devices deepen clinical adoption, supporting mid‑term revenue resilience and higher lifetime consumable attachment rates across geographies.
Bears Say
Thin Net Margins & Earnings VolatilityNet profitability remains thin and historically volatile, which weakens the durability of improvements. Low net margins limit the firm's ability to absorb cost inflation, tariffs or temporary procedure declines, and past swings into loss territory suggest earnings could retrace if growth or margin momentum stalls in the coming months.
China Implant VBP / Channel DestockingVolume‑based procurement (VBP) timing and scope in China create structural uncertainty for implant demand and distributor stocking patterns. Channel destocking can materially depress near‑term revenues and distort comparables; uncertainty over rollout means revenue and margin headwinds could persist for multiple quarters.
Meaningful Debt And Low ROEWhile leverage is manageable, absolute debt and low ROE signal capital is not yet delivering strong returns. Meaningful debt limits strategic flexibility for larger inorganic moves and increases sensitivity to any earnings setback, making sustained improvement in return metrics a near‑term imperative for durable financial health.
Envista Holdings News
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $351.13 and its highest was $400.00 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $75.62B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is Aug 05, 2026 which is in 7 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on May 06, 2026. The company reported $6.28 earnings per share for the quarter, beating the consensus estimate of $5.442 by $0.837.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Undervalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 5.84.
How many shares outstanding does Envista Holdings Corp have?
Currently, no data Available
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $6.28 in its last earnings report, beating expectations of $5.442. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in MX:NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$523.30 (41.05% Upside)
$523.30 (41.05% Upside)
Blogger Sentiment
Bullish
MX:NVST Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.38%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.04%
Trailing 12-Months
Company Description
Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Company Deck
NVST Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed broad-based operational and commercial progress: healthy top-line growth (9.5% core, ~4% normalized), margin expansion (gross margin +100 bps, EBITDA margin +120 bps), strong EPS improvement (+50%), meaningful new-product momentum, accretive tuck-in M&A, and continued capital returns (incremental $300M buyback). Key near-term headwinds include China implant destocking ahead of VBP, elevated tariff costs (~$11M), Q1 negative FCF due to CapEx, and geopolitical-driven inflation/freight risks — all of which management has identified and presented mitigation plans for. Overall, the positives on growth, margins, product launches and capital allocation materially outweigh the manageable near-term challenges.View all MX:NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$523.30
▲(41.05% Upside)